On day 0, ex vivo analysis of PBs revealed significantly lower frequencies of IgD− PBs, IgM− CS PBs, and IgM+ PBs in the CVID patients in comparison to the HCs (Figure 2F–H). Here, CD40LG is linked to common variable immunodeficiency.